4 results for author:"Paulding C." in Literature citations
Results Customize
› Repeat search in UniProtKB (20)
| Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Jacquemont S., Curie A., des Portes V., Torrioli M.G., Berry-Kravis E., Hagerman R.J., Ramos F.J., Cornish K., He Y., Paulding C. et al. Sci Transl Med 3:64ra1-64ra1(2011) · Mapped (8) |
| A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Singer J.B., Lewitzky S., Leroy E., Yang F., Zhao X., Klickstein L., Wright T.M., Meyer J., Paulding C.A. Nat. Genet. 42:711-714(2010) · Mapped (808) |
| DOCK4, a GTPase activator, is disrupted during tumorigenesis. Yajnik V., Paulding C., Sordella R., McClatchey A.I., Saito M., Wahrer D.C.R., Reynolds P., Bell D.W., Lake R., van den Heuvel S. et al. |
| The Tre2 (USP6) oncogene is a hominoid-specific gene. Paulding C.A., Ruvolo M., Haber D.A. Proc. Natl. Acad. Sci. U.S.A. 100:2507-2511(2003) · UniProtKB (17) · Mapped (2) |